Your browser doesn't support javascript.
loading
Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension.
Jansa, Pavel; Ambroz, David; Aschermann, Michael; Cerný, Vladimír; Dytrych, Vladimír; Heller, Samuel; Kunstýr, Jan; Lindner, Jaroslav; Linhart, Ales; Niznanský, Matús; Padour, Michal; Prskavec, Tomás; Siranec, Michal; Edwards, Susan; Gressin, Virginie; Kuhn, Matyás; Di Scala, Lilla.
Affiliation
  • Jansa P; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic.
  • Ambroz D; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic.
  • Aschermann M; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic.
  • Cerný V; Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic.
  • Dytrych V; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic.
  • Heller S; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic.
  • Kunstýr J; Department of Anesthesiology and Intensive Care, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic.
  • Lindner J; 2nd Department of Surgery, Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic.
  • Linhart A; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic.
  • Niznanský M; 2nd Department of Surgery, Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic.
  • Padour M; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic.
  • Prskavec T; 2nd Department of Surgery, Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic.
  • Siranec M; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic.
  • Edwards S; Actelion Pharmaceuticals Ltd., A Janssen Pharmaceutical Company of Johnson & Johnson, 4123 Allschwil, Switzerland.
  • Gressin V; Actelion Pharmaceuticals Ltd., A Janssen Pharmaceutical Company of Johnson & Johnson, 4123 Allschwil, Switzerland.
  • Kuhn M; Data Analysis Department, Institute of Biostatistics and Analysis Ltd., 602 00 Brno, Czech Republic.
  • Di Scala L; Actelion Pharmaceuticals Ltd., A Janssen Pharmaceutical Company of Johnson & Johnson, 4123 Allschwil, Switzerland.
J Clin Med ; 11(20)2022 Oct 20.
Article in En | MEDLINE | ID: mdl-36294508
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: J Clin Med Year: 2022 Type: Article Affiliation country: Czech Republic
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: J Clin Med Year: 2022 Type: Article Affiliation country: Czech Republic